The World’s Largest Pharmaceutical Summit Reaches Record Highs as Global Leaders Join to Discuss Real Innovation and Value to Patients.

eyeforpharma, London (January 16, 2014): Attendance for eyeforpharma Barcelona, the world’s largest commercial pharmaceutical event is up by 20% on last year. Numbers continue to rise as pharma brands gather to demonstrate their commitment to improving patient value. 

The shift towards patient value has taken an upward turn, as the customers voice becomes even stronger. Eyeforpharma Barcelona will address corporate practices and demonstrate new innovations to ensure the customer is at the forefront of business decisions.

Attendance so far includes executives from Janssen, Celgene, Bayer, GSK, LEO Pharma, Novartis, Takeda, Eli Lilly, Sanofi, Boehringer Ingelheim, Daiichi Sankyo Europe, Abbvie and many more who are looking to demonstrate real value to their customers.

Joining the eyeforpharma summit, Albert van Eijk, Director Oncology at Boehringer Ingelheim shares why he will be joining his peers in their decision to bring value to patients in 2014;

“The theme of value is so crucial now and anyone abandoning these partnerships will pay the price in the future. eyeforpharma have definitely moved with the industry to provide what we need to be delivering in sales and marketing, I'm excited for the summit”

eyeforpharma Barcelona will be taking place 18-20thMarch, 2014. For more information on the summit, to see who else will be in attendance, or to find out how this year’s agenda will influence your future business practices visit the official website.

For more information contact:

Lucy Fisher

EyeforPharma
(+44) 207-375-7225
lfisher@eyeforpharma.com